Phase II study: Neo-adjuvant chemotherapy (NAC) with fudr (F), leucovorin (L), oxaliplatin (O), and docetaxel (D) (FLOD) in chemo-naïve operable esophageal adenocarcinoma (EAC)

Journal article

Peer reviewed

B Ardalan, S Spector, D Mezentsev, M. A Molina, I Reis, P Ganjei-Azar, M Sapp, J Rios, D Franceschi and A. S Livingstone

Journal of clinical oncology, Vol.26(15_suppl), pp.15503-15503

2008-05-20

Metrics

22 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Phase II study: Neo-adjuvant chemotherapy (NAC) with fudr (F), leucovorin (L), oxaliplatin (O), and docetaxel (D) (FLOD) in chemo-naïve operable esophageal adenocarcinoma (EAC)
Creators: B Ardalan
S Spector
D Mezentsev
M. A Molina
I Reis
P Ganjei-Azar
M Sapp
J Rios
D Franceschi
A. S Livingstone
Publication Details: Journal of clinical oncology, Vol.26(15_suppl), pp.15503-15503
Academic Unit: Miller School of Medicine; UMMG Department of Public Health Sciences Research; UMMG Department of Surgery; UMMG Dept of Medicine - Hematology/Oncology; UMMG Dept of Surgery - Div of Surgical Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031619720702976